行情

OXFD

OXFD

Oxford Immunotec
NASDAQ

实时行情|Nasdaq Last Sale

16.38
-0.12
-0.73%
已收盘, 16:00 11/14 EST
开盘
16.48
昨收
16.50
最高
16.51
最低
16.18
成交量
7.22万
成交额
--
52周最高
18.60
52周最低
11.88
市值
4.33亿
市盈率(TTM)
13.91
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

OXFD 新闻

  • 京东第三季度净收入同比增28.7% 核心指标加速增长
  • 新浪财经.1小时前
  • 阿里巴巴屁股后为何带"-SW"?港股小尾巴是怎么回事?
  • 新浪网.1小时前
  • 京东第三季度净利润为31亿元 同比增长160.6%
  • 新浪科技.1小时前
  • 阿里香港发行价不高于188港元 集资额高至137亿美元
  • 新浪财经-自媒体综合.1小时前

更多

所属板块

先进医疗设备和技术
+0.11%
医疗设备和用品
+0.16%

热门股票

名称
价格
涨跌幅

OXFD 简况

Oxford Immunotec Global PLC,is a diagnostics company. It is focused on developing and commercializing tests for under-served immune-regulated conditions. Its product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and immune-oncology. It offers a range of assays for tick-borne diseases, such as Lyme disease, obtained through the acquisitions of Imugen and Immunetics. Tick-borne disease is the collective name for diseases passed to humans through the bite of an infected tick. Its diagnostic tests for tick-borne infections include multiple laboratory developed tests (LDTs). Its tick-borne disease tests utilize molecular methods (such as polymerase chain reaction) and techniques to prosecute the immune system. It has a series of assays for use in blood screening, building upon its expertise in tick-borne disease.
展开

Webull提供Oxford Immunotec Global PLC的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。